IFP Advisors, Inc - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$0750.0%0.00%
Q4 2017$0
-100.0%
75
-99.3%
0.00%
-100.0%
Q3 2017$15,000
-40.0%
10,120
+11.0%
0.00%0.0%
Q2 2017$25,000
-24.2%
9,120
+12.3%
0.00%0.0%
Q1 2017$33,000
-2.9%
8,1200.0%0.00%
-50.0%
Q4 2016$34,000
+277.8%
8,120
+515.2%
0.00%
Q3 2016$9,000
+12.5%
1,3200.0%0.00%
Q2 2016$8,000
-55.6%
1,320
-47.1%
0.00%
-100.0%
Q4 2015$18,0002,4950.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q1 2016
NameSharesValueWeighting ↓
IMS Capital Management 246,966$1,778,0002.19%
WELCH & FORBES LLC 902,286$6,496,0000.21%
Alambic Investment Management, L.P. 25,100$181,0000.11%
EMERSON INVESTMENT MANAGEMENT, LLC 74,175$534,0000.10%
Hayek Kallen Investment Management 10,965$79,0000.06%
Yellowstone Partners, LLC 10,045$72,0000.03%
Ausdal Financial Partners, Inc. 7,750$56,0000.03%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 29,647$213,0000.03%
GROUP ONE TRADING, L.P. 61,856$445,0000.01%
Cambridge Investment Research Advisors, Inc. 10,500$76,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders